Coronavirus disease 2019 (COVID-19). Antibody testing interim guidelines. Testing overview, and information for healthcare professionals.
Emergency use authorizations for medical devices. Coronavirus disease 2019 (COVID-19) emergency use authorizations for medical devices. EUA authorized serology test performance.
|Positive, n (%)||Negative, n (%)||Not available, n (%)|
|Positive (16.1%; n=269)||51 (19)||217 (80.6)||1 (0.4)|
|Negative (83.7%; n=1400)||15 (1.0)||1372 (98.0)||13 (1.0)|
|Equivocal (0.11%; n=2)||0||2 (100)||0|
|First author, year||Sample size (N)||Timing during pregnancy||Study period||Location||Positive seroprevalence results for SARS-CoV-2 antibodies (%)|
|Flannery et al,|
|1293||Antepartum and delivery admission||April 4, 2020, to June 3, 2020||Philadelphia, PA, USA||6.2|
|Zöllkau et al,|
|234||Delivery admission||April 6, 2020, to May 13, 2020||Jena, Thuringia, Germany||0.6|
|Cosma et al,|
|138||First trimester||April 16, 2020, to June 4, 2020||Turin, Piedmont, Italy||10.1|
|Current study||1671||Delivery admission||May 27, 2020, to July 24, 2020||New York City and Long Island, NY, USA||16.1|
- Coronavirus disease 2019 (COVID-19). Antibody testing interim guidelines. Testing overview, and information for healthcare professionals.(Available at:)https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.htmlDate: 2020Date accessed: September 28, 2020
- Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 states, March 1–30, 2020.MMWR Morb Mortal Wkly Rep. 2020; 69: 458-464
- Emergency use authorizations for medical devices. Coronavirus disease 2019 (COVID-19) emergency use authorizations for medical devices. EUA authorized serology test performance.(Available at:)https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performanceDate: 2020Date accessed: August 1, 2020
- SARS-CoV-2 seroprevalence among parturient women in Philadelphia.Sci Immunol. 2020; 5eabd5709
- The “scar” of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy.J Med Virol. 2020; ([Epub ahead of print])
- Period prevalence of SARS-CoV-2 in an unselected sample of pregnant women in Jena, Thuringia.Z Geburtshilfe Neonatol. 2020; 224: 194-198
- New York City Health website. COVID-19: data.(Available at:)
- Temporal dynamics in viral shedding and transmissibility of COVID-19.Nat Med. 2020; 26: 672-675
The authors report no conflict of interest.